Among these, CCL25 mediated 2 pathways, M-CSF1 mediated 7 pathways, and FGF21 mediated 12 pathways, suggesting different inflammatory factors may influence GBM development through distinct metabolic pathways. This evidence concerns the gene CCL25 and glioblastoma.